CVM
MRNA icon

Cheviot Value Management’s Moderna MRNA Stock Holding History

Cheviot Value Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$630 Hold
9
– – ﹤0.01% 398
2026
Q1 		$457 Hold
9
– – ﹤0.01% 388
2025
Q4 		$408 Hold
9
– – ﹤0.01% 380
2025
Q3 		$228 Hold
9
– – ﹤0.01% 419
2025
Q2 		$235 Hold
9
– – ﹤0.01% 405
2025
Q1 		$251 Buy
+9
New +$319 ﹤0.01% 427

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Cheviot Value Management's MRNA Position: Q2 2026 in Review

Cheviot Value Management held its Moderna (MRNA) position steady in Q2 2026 at 9 shares worth $630. The position accounts for ﹤0.01% of the portfolio, ranked #398.

Cheviot Value Management first reported a position in MRNA in Q1 2025 and has held it in 6 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Cheviot Value Management held 9 shares of Moderna worth $630 as of Q2 2026.
  • Cheviot Value Management left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Cheviot Value Management's portfolio in Q2 2026, its #398 holding.
  • Cheviot Value Management first reported a position in Moderna in Q1 2025 and has held it in 6 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Cheviot Value Management's 13F filing for Q2 2026, filed 6 Aug 2026.